Marshall Mazepa

14PUBLICATIONS
29CO-AUTHORS
Tumour immunologyAutoimmunityHaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Feb 13, 2025
Multicenter Prospective Pilot Study Identifying Thrombomodulin as a Potential Biomarker for Neurocognitive Outcomes in Immune Thrombotic Thrombocytopenic Purpura.

Aaron B Boothby, Michael D Evans, Shangbin Yang

|Dec 03, 2024
Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab era.

Ayotola Fatola, Michael D Evans, Jenna Brown

|Sep 02, 2022
Caplacizumab for congenital thrombotic thrombocytopenic purpura.

Aaron Boothby, Marshall Mazepa

|Jul 07, 2022
Race, rituximab, and relapse in TTP.

Shruti Chaturvedi, Ana G Antun, Andrew M Farland

|Jul 23, 2020
Therapeutic plasma exchange taper does not decrease exacerbations in immune thrombotic thrombocytopenic purpura patients.

Jay S Raval, Marshall A Mazepa, Marian A Rollins-Raval

|Feb 27, 2020
Opioid exposure in haemophilia patients is common and underreported.

Skye J Peltier, Marshall A Mazepa, Rebecca L Freese

Pageof 3

Frequent Collaborators

6 joint publications

Jay S Raval

4 joint publications

Michael D Evans

4 joint publications

Meera Sridharan

4 joint publications

Ming Yeong Lim